ViaDerma Inc (VDRM)

[Mistral]

I called the USPTO. I referenced Application Serial #13/066,705 attached to Published Application US 2012-0070390 A1 - TOPICAL DRUG DELIVERY SYSTEM WITH DUAL CARRIERS.

There is no Final Action with this Published Application. The last Transaction is dated November 15, 2016. An Information Disclosure Statement is being considered.

The gentleman was very kind and unable to provide information beyond what we see in the Pair database. He did say he didn't want to get in the middle of a dispute and could not discuss anything with shareholders--only the patent inventors.

He suggested calling the Attorney. I gave him the name of David Resnick which is at the top of the list on the Attorney/Agent tab in the database. He confirmed this is the proper contact and gave me his phone number as 617-345-6057. I won't be calling him.

David S. Resnick
Nixon Peabody LLP
100 Summer Street
Boston MA 02110-2131



Here is a link to the Global Dossier associated with these numbers.

https://globaldossier.uspto.gov/#/result/application/US/13066705/652288

I placed patent information in my section of the iBox for a reason--so newcomers don't have to cycle through historical messages to get up to speed.

What is clear is that Phillips/Otiko and Keough use two different Patent-Pending Application Numbers for the same invention. This is the dispute.

Keough has Trademarked Site Specific Penetration Technology for this invention. If you search on this term in Justia, you will see a link to this published patent application. Dakota Life Sciences has an R&D pipeline and products soon to hit the market. They are direct competition to vdrm and probably have much more to offer.

http://dakotalifesci.com

Keough has stated his intention to protect their IP. That message is also linked in the iBox and below. Pharmacline was the Applicant. They are aka Thru Pharma and Dakota Life Sciences. Dakota has merged with Kasten OTC:PK KAST

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129232062

Otiko cannot submit a non-provisional application for this invention and expect it to be published. It's on him to prove he is designing something completely different and has no interest in future litigation.